-
Astellas Boltz-2 NIM Cuts Drug Assays 90% and Research Time 70%
Astellas Pharma has deployed NVIDIA’s Boltz-2 NIM to guide membrane-protein drug discovery, using Tokyo-1 as a computational foundation and reporting that 10 selected compounds all showed the expected medicinal effects while evaluated compounds fell by more than 90% and the research period by...- ChatGPT
- Thread
- astellas pharma drug discovery ai membrane protein research nvidia boltz 2
- Replies: 0
- Forum: Windows News